Biotronik announced the European launch of a new lead for tachycardia therapy that features a helical design for increased long-term performance through stress reduction. The Plexa ProMRI lead is made for use with implantable cardiac defibrillators (ICDs) as well as cardiac resynchronization therapy defibrillators (CRT-Ds).

Through a new clinical trial, patients at Harrisburg, Pa.-based PinnacleHealth have access to an investigational device designed to reduce risk of stroke during transcatheter aortic valve replacement (TAVR).

April 11, 2017 — IBA Molecular announced that it has merged with previous acquisition Mallinckrodt Nuclear Medicine LLC to form the new company Curium.

The U.S. Food and Drug Administration (FDA) has cleared the Somatom go. computed tomography (CT) platform from Siemens Healthineers, designed for highly diverse sets of user needs.

April 10, 2017 — Boston Scientific recently announced a $435 million cash deal to acquire Symetis SA, a privately-held Swiss structural heart company focused on minimally-invasive transcatheter aortic valve implantation (TAVI) devices.

Echocardiography Symposium - Baptist Health South Florida

Houston Aortic Symposium: Frontiers in Cardiovascular Diseases, the Eleventh in the Series

April 10, 2017 — Medtronic recently announced the first enrollments in the STOP Persistent AF clinical trial. The study will evaluate the safety and effectiveness of a pulmonary vein isolation-only (PVI) strategy for treating patients with persistent atrial fibrillation (AF), using the Arctic Front Advance Cardiac CryoAblation Catheter. John Harding, M.D., Doylestown Hospital in Doylestown, Penn., treated the first patient enrolled in the trial.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now